SCK CEN And Quirem Medical Start Producing Ho-166 Microspheres At BR2 Reactor
SCK CEN And Quirem Medical Start Producing Ho-166 Microspheres At BR2 Reactor SCK CEN and Quirem Medical announce the first production of holmium-166 microspheres for patient use at the BR2 reactor in Mol, Belgium. A first clinical QuiremSpheres® patient procedure took place with radioactive holmium-166 microspheres, an innovative product for treating liver cancer patients. QuiremSpheres is…